In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes.
Neutrophil granulocytes play an important role in atherogenesis also through their free radical generation. According to recent studies, a point of action by which estrogens can provide protection against atherosclerosis is their inhibiting effect on superoxide anion production. The aim of our study was to test whether this means a common effect of steroids on superoxide production, or whether various steroid hormones have different action on superoxide generation of human granulocytes. Neutrophils were separated from the blood samples of twelve healthy volunteers. Isolated cells were incubated with different concentrations (10(-9), 10(-8), 10(-7) M) of hydrocortisone, aldosterone, cortexolone, 17-beta-estradiol, progesterone, and testosterone. Superoxide anion production was determined by photometry using the reduction of ferricytochrome-C. Compared to that of control cells neutrophils incubated with 17-beta-estradiol, progesterone, testosterone and hydrocortisone showed significantly reduced superoxide production. No significant alteration of superoxide anion production was found after the incubation of cells with aldosterone and cortexolone. It is concluded that similarly to estradiol other sex steroids and cortisol can inhibit the free radical production of human granulocytes, but mineralocorticoid aldosterone and Reichstein's substance S do not show such activity. Our results provide new evidence supporting the theory that certain types of steroid hormones have antioxidant capacity. This may give further reasons for investigating the molecular background of the existence or absence of this property and thus might lead to the development of new free radical scavengers.
Békési
G
G
Second Department of Medicine, Semmelweis University, Szentkirályi utca 46, H-1088, Budapest, Hungary. SB@bel2.sote.hu
Kakucs
R
R
Várbíró
S
S
Rácz
K
K
Sprintz
D
D
Fehér
J
J
Székács
B
B
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000494:pharmacology; D000838:Anions; D003350:Cortodoxone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D011374:Progesterone / Q000494:pharmacology; D012997:Solvents / Q000494:pharmacology; D013256:Steroids / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism*; D013739:Testosterone / Q000494:pharmacology
D000838:Anions; D012997:Solvents; D013256:Steroids; D013481:Superoxides; D013739:Testosterone; D000450:Aldosterone; D011374:Progesterone; D004958:Estradiol; D003350:Cortodoxone; D006854:Hydrocortisone